farxiga

Generic: dapagliflozin

Labeler: cardinal health 107, llc
NDC Directory HUMAN PRESCRIPTION DRUG NDA Inactive Finished

Drug Facts

Product Profile

Brand Name farxiga
Generic Name dapagliflozin
Labeler cardinal health 107, llc
Dosage Form TABLET, FILM COATED
Routes
ORAL
Active Ingredients

dapagliflozin propanediol 10 mg/1

Manufacturer
Cardinal Health 107, LLC

Identifiers & Regulatory

Product NDC 55154-6933
Product ID 55154-6933_38e8882e-539a-43cd-a916-48c69b8ac782
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category NDA
Application Number NDA202293
Marketing Start 2008-01-14
Marketing End 2026-07-31

Pharmacologic Class

Classes
sodium-glucose cotransporter 2 inhibitor [epc] sodium-glucose transporter 2 inhibitors [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 551546933
Hyphenated Format 55154-6933

Supplemental Identifiers

RxCUI
1486977 1486981 1488569 1488574
UPC
0303106210305 0355154693289
UNII
887K2391VH

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name farxiga (source: ndc)
Generic Name dapagliflozin (source: ndc)
Application Number NDA202293 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 10 mg/1
source: ndc
Packaging
  • 840 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (55154-6933-8)
source: ndc

Packages (1)

55154-6933-8 840 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (55154-6933-8)

Ingredients (1)

dapagliflozin propanediol (10 mg/1)

Linked Drug Pages (1)

FARXIGA ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "38e8882e-539a-43cd-a916-48c69b8ac782", "openfda": {"upc": ["0303106210305", "0355154693289"], "unii": ["887K2391VH"], "rxcui": ["1486977", "1486981", "1488569", "1488574"], "spl_set_id": ["40cc4f5d-bcf6-4016-9d1e-838bbc4bdddc"], "manufacturer_name": ["Cardinal Health 107, LLC"]}, "finished": true, "packaging": [{"sample": false, "description": "840 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (55154-6933-8)", "package_ndc": "55154-6933-8", "marketing_end_date": "20260731", "marketing_start_date": "20150105"}], "brand_name": "FARXIGA", "product_id": "55154-6933_38e8882e-539a-43cd-a916-48c69b8ac782", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["Sodium-Glucose Cotransporter 2 Inhibitor [EPC]", "Sodium-Glucose Transporter 2 Inhibitors [MoA]"], "product_ndc": "55154-6933", "generic_name": "DAPAGLIFLOZIN", "labeler_name": "Cardinal Health 107, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "FARXIGA", "active_ingredients": [{"name": "DAPAGLIFLOZIN PROPANEDIOL", "strength": "10 mg/1"}], "application_number": "NDA202293", "marketing_category": "NDA", "marketing_end_date": "20260731", "marketing_start_date": "20080114"}